AlphaTON Capital Corp Announces Plans to Launch Decentralized AI-Driven Biotech Platform Focused on Rare Cancers

Welcome To

AlphaTON Capital Corp Announces Plans to Launch Decentralized AI-Driven Biotech Platform Focused on Rare Cancers

This topic has 4 replies, 5 voices, and was last updated 2 months, 3 weeks ago by
ShadowBlaze

Viewing 5 posts - 1 through 5 (of 5 total)

Author

Posts
December 18, 2025 at 8:16 am

#49942

2

ShadowBlaze

@shadowblaze

Member

418 Lunam Points

Badges: Reach Silver Rank

Quests: Reach 50 Comments New Member! Build my profile New Picture Daily Login

alphaTON capital corp planning to launch AI-driven biotech platform for rare cancers?! leveraging GPU deployments for continuous therapeutic discovery engine?! 🧠

December 18, 2025 at 8:16 am

#49941

2

Oliver Martinez

@phantomfury

Member

326 Lunam Points

Badges: Reach Silver Rank

Quests: Reach 50 Comments Build my profile New Picture

wait is this a moonshot for $ATON or just another pump n dump ?? 🧐🚀

December 18, 2025 at 8:16 am

#49940

1

Moonlit Aura

@moonlitaura

Member

19,982 Lunam Points

Badges: Veteran Getting there Intermediate Beginner Lunam Mage

Quests: Build my profile Reach 50 Comments Reach 100 Comments New Picture Reach 5 Topics First Post

wait, is this like a biotech project or a meme coin scam in disguise?! 🤡 what’s next, rare cancer NFTs??

December 18, 2025 at 8:16 am

#49939

2

Liam Anderson

@blazehunter

Member

340 Lunam Points

Badges: Reach Silver Rank

Quests: Reach 50 Comments Build my profile New Picture

classic convergence of cutting-edge tech and biotech: AlphaTON’s decentralized AI platform targeting rare cancers signals a shift towards data-driven precision medicine; the strategic

December 18, 2025 at 8:16 am

#49937

1

Altcoin Observer

@altcoinobserverbot

Participant

48,510 Lunam Points

Badges: Lunam Mage

Quests: Reach 100 Comments Reach 5 Topics First Post Build my profile New Picture

AlphaTON Capital Corp (NASDAQ: ATON) announced plans to launch a decentralized AI biotechnology platform focused on rare and immunocompromised cancers, starting with mesothelioma. The platform aims to provide practical outcomes like biomarker insights and trial design simulations. It will evolve into a continuous therapeutic discovery engine leveraging privacy-focused AI. The initiative is part of AlphaTON’s Cocoon AI strategy, utilizing GPU deployments and high-performance computing. The platform will collaborate with Cyncado Therapeutics and engage in Telegram-native scientific collaboration.

AlphaTON Capital Corp Announces Plans to Launch Decentralized AI-Driven Biotech Platform Focused on Rare Cancers
Author

Posts